CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

VersaSuite

VersaSuite is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Schwartz Group

The Schwartz Group is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Society of Plastic Surgeons

Since 1975, PSEF has provided more than $5. 3 million to plastic surgery researchers for the development of innovative procedures and treatments that benefit reconstructive and cosmetic patients today. Funding for plastic surgery research is made

Medtronic Navigation

Medtronic Navigation is a Louisville, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Partnership of Illinois

Community Health Partnership of Illinois (CHP) is a non-profit organization that provides high quality, patient centered healthcare to uninsured, underserved, migrants, seasonal agricultural workers and their families across rural and urban communities...